Selective unresponsiveness to HBsAg vaccine in newborns related with an in utero passage of hepatitis B virus DNA

Vaccine

Volumn 15, Issue 10, 1997, Pages 1095-1100

  Lazizi, Y ^a   Badur, S ^b   Perk, Y ^c   Ilter, O ^c   Pillot, J ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b Faculty of Medicine   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

HBsAg; HBV vaccine; Immune tolerance; Vaccination

Indexed keywords

ANATOXAL; GENEVAC B; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; PNEUMOCOCCUS POLYSACCHARIDE; POLIOMYELITIS VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG; VIRUS DNA;

ANTIBODY PRODUCTION; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN MONITORING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERODIAGNOSIS; VACCINATION;

AGE FACTORS; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS, CHRONIC; HUMANS; IMMUNE TOLERANCE; INFANT; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0030848213     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00005-4     Document Type: Article

References (23)

1. Decker, R.H. Diagnosis. Viral Hepatitis (Eds Zuckerman, A.J. and Thomas, H.C.). Churchill Livingstone, London, 1993, pp. 165-184
2. Beasley, R.P., Hwang, L.Y., Chin-Yun Lee, G., Lan, C., Roan, C.H. and Huang, F.Y. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983, ii, 1099-1102
3. Ip, H.M.H., Lelie, P.N., Wong, V.C.W., Kuhns, M.C. and Reesink, H.W. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989, i, 406-410
4. Tong, M.J., Sinatra, F.R., Thomas, D.W., Nain, P.V., Merrit, R.J. and Wang, D.W. Need for immunoprophylaxis in infants born to HBsAg positive carrier mothers who are HBe Ag negative. J. Pediatr. 1984, 105, 945-947
5. Alexander, G.J. and Eddelston, A.L. Does maternal antibody to core antigen prevent recognition of transplacental transmission of hepatitis B virus infection?. Lancet 1986, i, 296-297
6. Lazizi, Y. and Pillot, J. Delayed clearance of HBV-DNA detected by PCR in the absence of viral replication. J. Med. Virol. 1993, 39, 208-213
7. Socle, G., Gluckman, E., Carosella, E., Brossard, Y., Lafon, C. and Brison, O. Search for maternal cells in human umbilical cord blood by polymerase chain reaction amplification of two minisatellite sequences. Blood 1994, 83, 340-344
8. Soulie, J.C., Devillier, P. and Santarelli, J. et al. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens. Vaccine 1991, 9, 545-548
9. Gross, S.M., Blaiss, J. and Herrod, H.G. Role of immunoglobulin subclasses and specific antibody determinations in the evaluation of recurrent infection in children. J. Pediatr. 1992, 121, 516-522
10. Mussi-Pinhata, M. and Goncalves, A.L. Serum immunoglobulin levels and incidence of infection during the first year of life in full-term and pre-term infants. J. Trop. Pediatr. 1989, 35, 147-153
11. Schödel, F., Wirtz, R. and Peterson, D. et al. Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes. J. Exp. Med. 1994, 180, 1037-1046
12. Whittle, H.C., Inskip, H., Hall, A.J., Mendy, M., Downes, R. and Hoare, S. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. Lancet 1991, 337, 747-751
13. Goudeau, A., Yvonnet, B. and Lesage, G. et al. Lack of anti-HBc IgM in neonates with HBsAg carrier mothers argues against transplacental transmission of hepatitis B virus infection. Lancet 1983, ii, 1103
14. Chang, H.K., Wang, B.Y., Yu, C.H., Wei, C.L. and Ting, L.P. A liver-specific nuclear factor interacts with the promoter region of the large surface protein gene of human hepatitis B virus. Mol. Cell. Biol. 1989, 9, 5189-5197
15. Lamelin, J.P., Zoulim, F. and Trepo, C. Lymphotropism of hepatitis B and C viruses; an update and a newcomer. Int. J. Clin. Lab. Res. 1995, 25, 1-6
16. Baischer, W., Brichta, A., Pfeffel, F., Hajji, M. and Leitner, H. Infection with hepatitis B or C virus of peripheral blood mononuclear cells in serologically negative chronic alcoholic patients. J. Hepatol. 1995, 23, 481
17. Feray, C., Zignego, A.L. and Samuel, D. et al. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. Transplantation 1990, 49, 1155-1158
18. Michalak, T.I., Pasquinelli, C., Guihot, S. and Chisari, F.V. Hepatitis B virus persistence after recovery from acute viral hepatitis. J. Clin. Invest. 1994, 93, 230-239
19. Korba, B.E., Cote, P.J. and Wells, F.V. et al. Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues. J. Virol. 1989, 63, 1360-1370
20. Oldstone, M.B.A. Viruses and diseases of the twenty first century. Am. J. Path. 1993, 143, 1241-1249
21. Del Canho, R., Grosheide, P.M., Schalm, S.W., de Vries, R.R.P. and Heijtink, R.A. Failure of neonatal hepatitis B vaccination: the role of HBV DNA levels in hepatitis B carrier mothers and HLA in neonates. J. Hepatol. 1994, 20, 483-486
22. Mauracher, C.A., Mitchell, L.A. and Tingle, A.J. Selective tolerance to the E1 protein of rubella virus in congenital rubella syndrome. J. Immunol. 1993, 151, 2041-2049
23. Gilbert, K.M. and Weigle, W.O. Tolerogenicity of resting and activated B cells. J. Exp. Med. 1994, 179, 249-258